Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study

Background: Infusion reactions (IRs) are the most common adverse events (AEs) of infliximab (IFX) treatment in patients with inflammatory bowel disease (IBD). Prophylactic premedication (PM) with corticosteroids or antihistamines prior to IFX infusions has been used in clinical practice, but its eff...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Med
Autori principali: Szymanska, Edyta, Dadalski, Maciej, Sieczkowska-Golub, Joanna, Jarzebicka, Dorota, Meglicka, Monika, Osiecki, Marcin, Wiernicka, Anna, Lebensztejn, Dariusz M., Korczowski, Bartosz, Kierkus, Jaroslaw
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8303466/
https://ncbi.nlm.nih.gov/pubmed/34300342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10143177
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi